Molecular Oncology · 2022 · 11 citations · 42 references
Life SciencesCancer BiologyOncologyCarcinogenesisGene ExpressionMolecular OncologyColorectal CancerRibosome BiogenesisRna InterferenceRna Polymerase I TranscriptionTranslation RegulationTumor Suppressor GenesDifferentiation-associated Growth ArrestMolecular Initiating EventsOncogenic Regulation Of Rna Polymerase I TranscriptionRna Polymerase I ActivityRna Polymerase I FunctionRna Polymerase I RegulationTerminal Differentiation ArrestZinc Finger Proteins
Ribosomal biogenesis and protein synthesis are deregulated in most cancers, suggesting that interfering with translation machinery may hold significant therapeutic potential. Here, we show that loss of the tumor suppressor adenomatous polyposis coli (APC), which constitutes the initiating event in the adenoma carcinoma sequence for colorectal cancer (CRC), induces the expression of RNA polymerase I (RNAPOL1) transcription machinery, and subsequently upregulates ribosomal DNA (rDNA) transcription. Targeting RNAPOL1 with a specific inhibitor, CX5461, disrupts nucleolar integrity, and induces a disbalance of ribosomal proteins. Surprisingly, CX5461-induced growth arrest is irreversible and exhibits features of senescence and terminal differentiation. Mechanistically, CX5461 promotes differentiation in an MYC-interacting zinc-finger protein 1 (MIZ1)- and retinoblastoma protein (Rb)-dependent manner. In addition, the inhibition of RNAPOL1 renders CRC cells vulnerable towards senolytic agents. We validated this therapeutic effect of CX5461 in murine- and patient-derived organoids, and in a xenograft mouse model. These results show that targeting ribosomal biogenesis together with targeting the consecutive, senescent phenotype using approved drugs is a new therapeutic approach, which can rapidly be transferred from bench to bedside.
42
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2019 · 21K citations · Full text
Comprehensive molecular characterization of human colon and rectal cancer
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Georgios Vlachogiannis, Somaieh Hedayat, Alexandra Vatsiou et al. · Science · 2018 · 2.1K citations · Full text
Medicine, Oncology, Pharmacology +17
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Daniele V. F. Tauriello, Sergio Palomo‐Ponce, Diana Stork et al. · Nature · 2018 · 1.8K citations
Medicine, Cancer Biology, Oncology +14